Related Experiment Video

Updated: May 7, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer

L Du1, Z Zhao2, X Ma2

  • 11] Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA [2] Department of Cellular and Structural Biology, UT Health Science Center at San Antonio, San Antonio, TX, USA.

Oncogene
|September 17, 2013
PubMed

Insights

Low disabled homolog 2 (DAB2) gene expression and high microRNA miR-93 levels correlate with poor lung cancer survival. MiR-93 promotes lung cancer by suppressing DAB2, highlighting a key pathway in tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Disabled homolog 2 (DAB2) is a tumor suppressor gene with downregulated expression in various cancers.
  • The specific role and regulatory mechanisms of DAB2 in lung cancer remain unclear.

Purpose of the Study:

  • To investigate the function of DAB2 in lung tumorigenesis.
  • To identify the mechanisms underlying DAB2 dysregulation in lung cancer.
  • To explore the clinical significance of the miR-93/DAB2 pathway in lung cancer progression.

Main Methods:

  • Analysis of DAB2 expression in lung tumor specimens and correlation with patient survival.
  • Assessment of DAB2's effect on lung cancer cell growth upon overexpression.
  • Identification of microRNA (miR-93) targeting DAB2 mRNA using in vitro and in vivo models.
  • Evaluation of miR-93 expression in tumors and its correlation with patient survival.

Main Results:

  • Low DAB2 levels in lung tumors significantly correlate with poor patient survival.
  • DAB2 overexpression inhibits lung cancer cell growth, confirming its tumor suppressor role.
  • MicroRNA miR-93 directly targets DAB2 mRNA, repressing its expression.
  • Overexpression of miR-93 promotes lung cancer cell growth by downregulating DAB2.
  • High miR-93 levels in tumors correlate with poor patient survival.

Conclusions:

  • The miR-93/DAB2 pathway plays a critical role in lung cancer progression.
  • DAB2 functions as a tumor suppressor in lung cancer, while miR-93 acts as an oncogene.
  • Both low DAB2 and high miR-93 expression are significant indicators of poor prognosis in lung cancer patients.

More Related Videos

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...